Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice
NCT03659110
·
clinicaltrials.gov ↗
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
BIOLOGICAL:
HPV 4
Sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention